Concepedia

Anjali Tikoo

AT

Statistics

Publications

15

Citations

1.4K

H-Index

14

Active since

1994

Affiliations

Ludwig Cancer Research(Current)

The Royal Melbourne Hospital

Peter MacCallum Cancer Centre

The University of Melbourne

Monash University

Anjali Tikoo is an author at Ludwig Cancer Research specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

1994–2012

15

Publications

15

HtrA2 Promotes Cell Death through Its Serine Protease Activity and Its Ability to Antagonize Inhibitor of Apoptosis Proteins

Anne M. Verhagen, John Silke, Paul G. Ekert et al. · Journal of Biological Chemistry · 2002 · 546 citations · Full text

An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice

Kathryn M. Kinross, Karen G. Montgomery, Margarete Kleinschmidt et al. · Journal of Clinical Investigation · 2012 · 216 citations · Full text

, , +20

An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin).

Anjali Tikoo, Mikael Varga, Vijaya Ramesh et al. · Journal of Biological Chemistry · 1994 · 150 citations · Full text

A Clue to the Therapy of Neurofibromatosis Type 2

Yumiko Hirokawa, Anjali Tikoo, John Huynh et al. · The Cancer Journal · 2004 · 101 citations

Physiological Levels of Pik3caH1047R Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ERα-Positive Tumors

Anjali Tikoo, Vincent Roh, Karen G. Montgomery et al. · PLoS ONE · 2012 · 66 citations · Full text

1–5 of 15